poisar

Stock

Profusa, Inc. PFSA

$1.70-9.57%

Overview

PFSA market data

Price History

PFSA price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PFSA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured
Profusa Files Resale Prospectus For Offer And Resale From Time To Time Of Up To 7,170,891 Shares Of Common Stock By Selling StockholdersBenzinga · Jul 7, 2026, 12:55 PM
Profuse Announces 1-For-25 Reverse Stock Split, Effective July 7Benzinga · Jul 2, 2026, 3:10 PM
Profusa Shareholders Approve Proposed Acquisition Of PanOmics Multi-Omics Diagnostics Platform, Debt-Conversion To Enhance Balance Sheet, And Approval Of Reverse Stock SplitBenzinga · Jun 24, 2026, 12:10 PM
Profusa Shareholders Approve Amendment For Effect One Or More Common Stock Splits At Ratio Of 1-To-5 To 1-For-200 Over Next Two YearsBenzinga · Jun 23, 2026, 5:20 PM
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen PlatformGlobenewswire Inc · Jun 12, 2026, 12:15 PM
Profusa To Trade On Nasdaq Capital Market, Effective May 15Benzinga · May 15, 2026, 11:40 AM
Profusa Receives Favorable Nasdaq Listing DeterminationGlobenewswire Inc · May 8, 2026, 11:00 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock